Embecta Corporation ( (EMBC) ) has issued an announcement.
Embecta announced today that it discontinued its insulin patch pump program and plans to initiate a restructuring plan.
Dynamic Technology Lab Private Ltd lessened its stake in Embecta Corp. (NASDAQ:EMBC – Free Report) by 6.4% during the 3rd ...
Hosted on MSN1dOpinion
New Strong Buy Stocks for December 2ndList today: Embecta Corp. EMBC: This medical device company has seen the Zacks Consensus Estimate for its current year ...
Kurdikar, CEO of Embecta (EMBC) said, “As our stand-up work nears completion and following an in-depth review of our ...
Embecta (EMBC) stock gains as BTIG upgrades the stock citing an end to its patch pump program announced with its Q4 FY24 ...
CEO Dev Kurdikar said the decision may “come as a surprise” as Embecta just received FDA clearance for a patch pump, but the ...
7d
On Tuesday, Embecta Corp (NASDAQ:EMBC) posted the fourth-quarter adjusted EPS of 45 cents, beating the consensus of 36 cents ...
Embecta also said it expects to earn between $2.70 and $2.90 a share on an adjusted basis for all of 2025, easily surpassing the average analyst estimate of $2.27 per share. Revenue is anticipated at ...
Zacks.com on MSN1dOpinion
Best Income Stocks to Buy for December 2ndHere are two stocks with buy rank and strong income characteristics for investors to consider today, December 2: Community ...
BofA raised the firm’s price target on Embecta (EMBC) to $20 from $17 and keeps an Underperform rating on the shares after the company ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback